http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3687982-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ce13a688a469973948fd501b553efb8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135 |
| filingDate | 2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ed0bf420d800a9b80d9e566c038e5cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7247d1d15950011485ba2a2fdf2989eb |
| publicationDate | 2020-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3687982-A1 |
| titleOfInvention | Methods of treating neurodegeneration |
| abstract | The present invention provides methods and compositions for treating a CNS disease, disorder, or injury ( eg , CNS demyelinating disease). The present invention relates to methods and compositions for preserving or protecting neuroaxonal activity in a subject, preferably a mammalian subject ( e.g. , a human) by administering one or more compositions that inhibit γ-glutamyl activity. transpeptidase in the human subject. |
| priorityDate | 2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 235.